Truvestments Capital LLC cut its stake in Procter & Gamble Company (The) (NYSE:PG - Free Report) by 40.8% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 14,262 shares of the company's stock after selling 9,827 shares during the period. Truvestments Capital LLC's holdings in Procter & Gamble were worth $2,431,000 at the end of the most recent reporting period.
A number of other hedge funds have also modified their holdings of PG. Nuveen LLC purchased a new position in shares of Procter & Gamble during the 1st quarter worth approximately $1,954,941,000. GAMMA Investing LLC increased its stake in shares of Procter & Gamble by 20,758.5% during the 1st quarter. GAMMA Investing LLC now owns 7,951,456 shares of the company's stock worth $1,355,087,000 after purchasing an additional 7,913,335 shares in the last quarter. Price T Rowe Associates Inc. MD increased its stake in shares of Procter & Gamble by 13.0% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 21,480,670 shares of the company's stock worth $3,660,737,000 after purchasing an additional 2,466,308 shares in the last quarter. Invesco Ltd. increased its stake in shares of Procter & Gamble by 19.8% during the 1st quarter. Invesco Ltd. now owns 13,493,604 shares of the company's stock worth $2,299,580,000 after purchasing an additional 2,228,151 shares in the last quarter. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its stake in shares of Procter & Gamble by 15.8% during the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 16,274,563 shares of the company's stock worth $2,728,430,000 after purchasing an additional 2,224,912 shares in the last quarter. 65.77% of the stock is owned by hedge funds and other institutional investors.
Procter & Gamble Trading Up 1.0%
Shares of PG traded up $1.48 during mid-day trading on Friday, reaching $157.13. The company had a trading volume of 5,317,408 shares, compared to its average volume of 6,701,783. The stock has a market cap of $368.07 billion, a price-to-earnings ratio of 24.14, a price-to-earnings-growth ratio of 4.11 and a beta of 0.37. The firm has a fifty day simple moving average of $156.55 and a 200-day simple moving average of $162.55. Procter & Gamble Company has a fifty-two week low of $149.91 and a fifty-two week high of $180.43. The company has a current ratio of 0.70, a quick ratio of 0.49 and a debt-to-equity ratio of 0.49.
Procter & Gamble (NYSE:PG - Get Free Report) last announced its quarterly earnings results on Tuesday, July 29th. The company reported $1.48 earnings per share for the quarter, beating analysts' consensus estimates of $1.42 by $0.06. The company had revenue of $20.89 billion for the quarter, compared to analyst estimates of $20.79 billion. Procter & Gamble had a net margin of 18.95% and a return on equity of 32.69%. Procter & Gamble's revenue for the quarter was up 1.7% on a year-over-year basis. During the same quarter last year, the business earned $1.40 EPS. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. On average, sell-side analysts anticipate that Procter & Gamble Company will post 6.91 EPS for the current fiscal year.
Procter & Gamble Dividend Announcement
The business also recently declared a quarterly dividend, which was paid on Friday, August 15th. Shareholders of record on Friday, July 18th were issued a $1.0568 dividend. This represents a $4.23 dividend on an annualized basis and a dividend yield of 2.7%. The ex-dividend date was Friday, July 18th. Procter & Gamble's dividend payout ratio (DPR) is 64.98%.
Analyst Ratings Changes
A number of research analysts have recently weighed in on the stock. Piper Sandler raised their price objective on shares of Procter & Gamble from $160.00 to $164.00 and gave the stock a "neutral" rating in a research note on Monday, May 5th. JPMorgan Chase & Co. reissued a "neutral" rating and set a $170.00 price objective (down from $178.00) on shares of Procter & Gamble in a research note on Friday, July 25th. Redburn Partners set a $161.00 target price on shares of Procter & Gamble in a research report on Thursday, May 1st. UBS Group set a $180.00 target price on shares of Procter & Gamble and gave the stock a "buy" rating in a research report on Wednesday, July 30th. Finally, BNP Paribas restated an "outperform" rating and set a $177.00 target price on shares of Procter & Gamble in a research report on Friday, August 15th. One equities research analyst has rated the stock with a Strong Buy rating, ten have given a Buy rating and seven have given a Hold rating to the company's stock. According to MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $175.12.
Check Out Our Latest Stock Analysis on PG
Insider Buying and Selling at Procter & Gamble
In related news, CEO Gary A. Coombe sold 10,194 shares of Procter & Gamble stock in a transaction on Thursday, August 21st. The shares were sold at an average price of $158.16, for a total transaction of $1,612,283.04. Following the transaction, the chief executive officer owned 34,978 shares in the company, valued at approximately $5,532,120.48. The trade was a 22.57% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, COO Shailesh Jejurikar sold 13,039 shares of Procter & Gamble stock in a transaction on Tuesday, August 19th. The shares were sold at an average price of $157.27, for a total transaction of $2,050,643.53. Following the transaction, the chief operating officer owned 28,036 shares in the company, valued at $4,409,221.72. The trade was a 31.74% decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 120,181 shares of company stock worth $18,918,012. Corporate insiders own 0.18% of the company's stock.
About Procter & Gamble
(
Free Report)
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Recommended Stories

Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report